Ezetimibe Plus Statin Reduces CV Events after ACS

Article Figures & Data

Figures

  • Figure 1.

    Primary End Point of the IMPROVE-IT Trial

    IMPROVE-IT, Improved Reduction of Outcomes: Vytorin (Ezetimibe/Simvastatin) Efficacy International Trial.Reproduced with permission from CP Cannon, MD.